| Ticker | Company | Market Cap | Dividend Yield | Payout Ratio | Last Dividend | Annual Dividend | Dividend Percentile | Dividend Dropped Count (L10Y) | Ex-dividend Date | Div. Payment Date |
|---|---|---|---|---|---|---|---|---|---|---|
| ALNY | ALNYLAM PHARMACEUTICALS INC | $42.28B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| THC | TENET HEALTHCARE CORP | $16.96B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| NBIX | NEUROCRINE BIOSCIENCES INC | $13.91B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $10.03B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| VISN | VISTANCE NETWORKS INC | $4.30B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| INDV | INDIVIOR PLC | $4.23B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| RSI | RUSH STREET INTERACTIVE INC | $4.06B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| VCYT | VERACYTE INC | $2.90B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| HCI | HCI GROUP INC | $2.08B | 1.00% | 9.30% | $0.4000 | $1.60 | 24% | 0 | 2026-02-20 | 2026-03-20 |
| HLMN | HILLMAN SOLUTIONS CORP | $2.02B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| FIVN | FIVE9 INC | $1.33B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| DFIN | DONNELLEY FINANCIAL SOLUTIONS INC | $1.24B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| TBLA | TABOOLACOM LTD | $1.01B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| UVE | UNIVERSAL INSURANCE HOLDINGS INC | $857.17M | 2.52% | 17.60% | $0.2900 | $0.77 | 56% | 9 | 2026-03-06 | 2026-03-13 |
| NRDS | NERDWALLET INC | $746.04M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| BWMX | BETTERWARE DE MEXICO SAPI DE CV | $705.28M | 3.21% | N/A | $0.2850 | $0.61 | 67% | 2 | ||
| LE | LANDS' END INC | $568.25M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| ORGO | ORGANOGENESIS HOLDINGS INC | $486.07M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| LTRX | LANTRONIX INC | $250.85M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| ELMD | ELECTROMED INC | $230.28M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| INFU | INFUSYSTEM HOLDINGS INC | $155.78M | N/A | 0.00% | N/A | N/A | N/A | N/A |
Use the proven Zen Ratings quant model to find stocks with high potential to beat the market. Stocks Zen-Rated "A" have beaten the market by +32.52% annually. Learn More